ArticleOncotarget2020
A novel format for recombinant antibody-interleukin-2 fusion proteins exhibits superior tumor-targeting properties
Tiziano Ongaro et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this papercites it